Clinical Trial Detail

NCT ID NCT02087176
Title A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications

lung non-small cell carcinoma

Therapies

Adavosertib

Pegfilgrastim

Age Groups: adult

No variant requirements are available.